Abingworth

Abingworth as of March 31, 2020

Portfolio Holdings for Abingworth

Abingworth holds 16 positions in its portfolio as reported in the March 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Personalis Ord (PSNL) 29.0 $44M 5.4M 8.00
Phathom Pharmaceuticals (PHAT) 20.5 $31M 1.2M 25.62
Crispr Therapeutics (CRSP) 14.6 $22M 519k 42.28
Soleno Therapeutics 10.4 $16M 7.0M 2.25
Exicure 6.8 $10M 7.0M 1.46
Sierra Oncology 5.7 $8.6M 877k 9.80
Sientra 3.1 $4.7M 2.4M 1.96
Verona Pharma Plc ads (VRNA) 2.5 $3.7M 902k 4.12
Paratek Pharmaceuticals 2.2 $3.2M 1.0M 3.11
Molecular Templates 1.8 $2.6M 200k 13.21
Artara Therapeutics 1.7 $2.6M 114k 23.00
Chiasma 0.9 $1.3M 371k 3.63
Aeglea Biotherapeutics 0.7 $1.1M 241k 4.59
Obseva Sa 0.1 $210k 88k 2.39
Cymabay Therapeutics 0.1 $191k 131k 1.46
Histogenics Corp Cmn 0.0 $2.0k 7.1k 0.28